(Q43134460)

English

Effects of the selective alpha 1a-adrenoceptor antagonist silodosin on ECGs of healthy men in a randomized, double-blind, placebo- and moxifloxacin-controlled study

scientific article published on 10 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Effects of the selective alpha 1a-adrenoceptor antagonist silodosin on ECGs of healthy men in a randomized, double-blind, placebo- and moxifloxacin-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

author name string

J Morganroth

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

H Lepor

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

L A Hill

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

W Volinn

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

G Hoel

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

language of work or name

0 references

publication date

10 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

87

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

609-613

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.265

21 January 2018

Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.265

21 January 2018

Alfuzosin delays cardiac repolarization by a novel mechanism

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.265

21 January 2018

The effect of moxifloxacin on QTc and implications for the design of thorough QT studies

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.265

21 January 2018

A statistical assessment of QT data following placebo and moxifloxacin dosing in thorough QT studies

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.265

21 January 2018

Alpha1-adrenoceptor subtypes and lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.265

21 January 2018

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.265

21 January 2018

Prediction of alpha1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.265

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2009.265

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43134460&oldid=1981403072"